Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001035443-25-000213
Filing Date
2025-12-15
Accepted
2025-12-15 17:38:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11613
  Complete submission text file 0001035443-25-000213.txt   13593
Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 6265780777
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by) CIK: 0001035443 (see all company filings)

EIN.: 954502084 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6798 Real Estate Investment Trusts
(CF Office: 05 Real Estate & Construction)

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Subject) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91017 | Film No.: 251572685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)